Levothyroxine / liothyronine
RxNorm 465675
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 465675 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: levothyroxine / liothyronine.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
MINPrescribable
Multiple Ingredients (MIN):
Levothyroxine / liothyronine
(Atom ID: 8689286)
PTPrescribable
Designated preferred name (PT):
Levothyroxine- and liothyronine-containing product
(Atom ID: 10806032)
FNPrescribable
Full form of descriptor (FN):
Product containing levothyroxine and liothyronine (medicinal product)
(Atom ID: 10307568)
Patient Education
Liotrix
Liotrix is used to treat hypothyroidism (a condition that results when the thyroid gland does not produce enough thyroid hormone). Symptoms of hypothyroidism include lack of energy, depression, constipation, weight gain, hair loss, dry skin, dry coarse hair, muscle cramps, decreased concentration, aches and pains, swelling of the legs, and increased sensitivity to cold. When taken correctly, liotrix can reverse these symptoms. Liotrix is also used to treat goiter (enlarged thyroid gland). This medication is also used to test for hyperthyroidism (a condition where the thyroid gland produces too much thyroid hormone). Liotrix is in a class of medications called thyroid agents. It works by supplying the thyroid hormones normally produced by the body.
[Learn More]
* Please review the disclaimer below.